CD123-targeted CAR-T immunotherapy 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Products		 012345678910
            
                                                                                                      
            
SZGIMI           
          
            
AvenCell Therap           
          
            
Hedy Group           
          
            
Avalon GloboCare           
          
            
Beijing Imunopharm           
          
            
Cellectis           
          
            
Chongqing Precision Biotech           
          
            
Fortress           
          
            
National Cancer Institute           
          
            
St. Jude Children's Research Hospital           
          
            
Tianjin First Central Hospital           
          
            
UT MD Anderson Cancer Center           
          
            
UTC Therap           
          
            
University of Pennsylvania           
          
            
Wuhan Bio–Raid           
          
            
Xinqiao Hospital           
          
            
iCell Gene Therap